Literature DB >> 2176199

Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma.

K Kiyosawa1, E Tanaka, T Sodeyama, K Furuta, S Usuda, M Yousuf, S Furuta.   

Abstract

Fifty-eight patients with chronic hepatitis C were followed for more than 7 years. Of them, 10 patients were found to develop hepatocellular carcinoma, 14 to develop liver cirrhosis, 30 to sustain chronic hepatitis, and 4 to show subsidence of hepatitis. Antibody to hepatitis C virus (anti-HCV) disappeared from the 4 patients whose hepatitis subsided, but it persisted in the remaining 54 patients. The mean titer of anti-HCV was almost the same at the stages of chronic hepatitis and of cancer in the 10 patients who developed hepatocellular carcinoma. These results indicate that chronic infection of hepatitis C virus may lead to hepatocellular carcinoma.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2176199      PMCID： PMC5917992          DOI： 10.1111/j.1349-7006.1990.tb02517.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


  9 in total

1.  Primary hepatocellular carcinoma following nonspecific non-B hepatitis with tumor DNA negative for HBV DNA.

Authors:  E B Cohen; D L Gang; J B Zeldis
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

2.  Detection of serum hepatitis C virus RNA.

Authors:  S Kaneko; M Unoura; K Kobayashi; K Kuno; S Murakami; N Hattori
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

3.  Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors:  J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.

Authors:  M Colombo; G Kuo; Q L Choo; M F Donato; E Del Ninno; M A Tommasini; N Dioguardi; M Houghton
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

5.  Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis.

Authors:  J H Gilliam; K R Geisinger; J E Richter
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

6.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

7.  Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma.

Authors:  M C Kew; M Houghton; Q L Choo; G Kuo
Journal:  Lancet       Date:  1990-04-14       Impact factor: 79.321

8.  Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.

Authors:  K Kiyosawa; Y Akahane; A Nagata; S Furuta
Journal:  Am J Gastroenterol       Date:  1984-10       Impact factor: 10.864

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728
  9 in total
  9 in total

Review 1.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Hepatitis C virus infection in a male homosexual cohort: risk factor analysis.

Authors:  O K Ndimbie; L A Kingsley; S Nedjar; C R Rinaldo
Journal:  Genitourin Med       Date:  1996-06

3.  Autopsy case of hepatocellular carcinoma associated with lupoid hepatitis and complicated by malignant lymphoma.

Authors:  Y Ikura; N Nagatomi; K Ohtani; S Harihara; T Yamamoto; H Kuwahara; M Sakurai
Journal:  Gastroenterol Jpn       Date:  1993-08

4.  Vaccination of chimpanzees against infection by the hepatitis C virus.

Authors:  Q L Choo; G Kuo; R Ralston; A Weiner; D Chien; G Van Nest; J Han; K Berger; K Thudium; C Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 5.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

6.  Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.

Authors:  J Bukh; R H Miller; M C Kew; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.

Authors:  S A Curley; F Izzo; A Gallipoli; M de Bellis; F Cremona; V Parisi
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

8.  Codelivery of IL-7 Augments Multigenic HCV DNA Vaccine-induced Antibody as well as Broad T Cell Responses in Cynomolgus Monkeys.

Authors:  Su-Hyung Park; Mi-Young Song; Hyo Jung Nam; Se Jin Im; Young-Chul Sung
Journal:  Immune Netw       Date:  2010-12-31       Impact factor: 6.303

Review 9.  Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries.

Authors:  Anoop Kumar; Manoj Kumar Rajput; Deepika Paliwal; Aakanksha Yadav; Reba Chhabra; Surinder Singh
Journal:  Indian J Med Res       Date:  2018-05       Impact factor: 2.375
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.